This study investigates multidimensional factors influencing depression and anxiety symptoms in multidrug-resistant tuberculosis (MDR-TB) patients, aiming to inform effective mental health intervention strategies. A cross-sectional study included 103 MDR-TB patients treated at our hospital from January 2021 to August 2024. Assessments utilized the Hospital Anxiety and Depression Scale (HADS), Connor-Davidson Resilience Scale (CD-RISC-10), and Perceived Social Support from Family Scale (PSS-Fa). Demographic and clinical data were collected. Statistical analyses (descriptive, correlation, multiple regression) were performed using SPSS 26.0. Depression and anxiety prevalence rates were 50.5% and 35.0%, respectively. Significant correlations linked depressive/anxious states with gender, activity levels, sleep quality, treatment stage, disease perception, healthcare experiences, family support, and resilience. Treatment stage, family support, and resilience emerged as key depression factors; gender, sleep quality, disease perception, family support, and resilience influenced anxiety. MDR-TB patients experience high depression and anxiety rates influenced by complex personal and environmental factors. Enhanced mental health education, personalized psychological support, optimized family involvement, and resilience training are crucial in clinical care to enhance mental health and treatment outcomes.

Na Li, Biao Fu, Yonghong Xu, Huanying Xiang, Haiyan Luo, Yinlai Fan, Runmei Zhu, Zhisong Zhu. A Multidimensional Analysis of Factors Influencing Depression and Anxiety among Multidrug-Resistant Tuberculosis Patients. International Journal of Frontiers in Medicine (2024), Vol. 6, Issue 9: 14-19. https://doi.org/10.25236/IJFM.2024.060903.

[1] Popoiag C C ,Gache C A ,Iosif C A , et al. Prevalence of Depression and Anxiety in Patients with Multidrug-Resistant Tuberculosis: An Analysis With DAS-21R[J].ARS Medica Tomitana, 2024, 30(1):1-5.

[2] Fu Ting, Huang Liju, Yang Jinjun, et al. Analysis of mental health status and influencing factors in 308 patients with multidrug-resistant tuberculosis[J]. Chinese Journal of Antituberculosis, 2020, 42(04): 366-371.

[3] Dan-Ni Z, Guang-Min Z, Yu-Hua D, et al. Prevalence and risk factors of anxiety and depression in patients with multi-drug/rifampicin-resistant tuberculosis[J]. Frontiers in Public Health, 2024, 12: 1372389.

[4] Gui Min, Chen Jingfang, Deng Guofang, et al. Correlation between anxiety, depression and medication compliance in patients with multidrug-resistant tuberculosis[J]. Chinese Journal of Contemporary Medicine, 2022, 29(8): 155-158.

[5] Liu K, Zhang Y, Qu S, et al. Prevalence and correlates of anxiety and depressive symptoms in patients with and without multi-drug resistant pulmonary tuberculosis in China[J]. Frontiers in Psychiatry, 2021, 12: 674891.

[6] Sun Zhenxiao, Liu Huaxue, Jiao Linying, et al. Reliability and validity of the Hospital Anxiety and Depression Scale[J]. Chinese Journal of Clinical Physicians: Electronic Edition, 2017 (2): 198-201.

[7] Ye Zengjie, Wang Zhenyu, Liang Muzi, et al. Application of the Chinese version of the 10-item resilience scale in patients with malignant tumors[J]. Chinese Journal of General Practice, 2018, 21(15): 1839.

[8] Procidano M E, Heller K. Measures of perceived social support from friends and from family: Three validation studies[J]. American journal of community psychology, 1983, 11(1): 1-24.

[9] Thomas B E, Shanmugam P, Malaisamy M, et al. Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review[J]. PloS one, 2016, 11(1): e0147397.

[10] Zhang Yanchun, Zheng Lijun. Evaluation of mental health status at home and investigation of influencing factors of middle-aged and elderly patients with pulmonary tuberculosis[J]. Nursing Practice and Research, 2020, 17(17): 38.

[11] Mehreen S, Khan M A, Basit A, et al. Frequency of depression in multidrug-resistant tuberculosis patients: an experience from a Tertiary care Hospital[J]. Pakistan Journal of Chest Medicine, 2015, 21(4): 149-54.

[12] Murugan Y, Patel N, Kumar V, et al. Mental Health Impacts of Multidrug-Resistant Tuberculosis in Patients and Household Contacts: A Mixed Methods Study[J]. Cureus, 2024, 16(5).

[13] Wang Xiujun, Gao Ning, Zhang Xiaoyun, et al. Correlation analysis between anxiety and depression and social support level in patients with drug-resistant pulmonary tuberculosis[J]. Chinese Journal of Modern Nursing, 2013 (36): 4493-4495.

[14] Sun Ying. Observation on the effect of psychological care on negative emotions and quality of life in patients with multidrug-resistant tuberculosis[J]. Chinese Medical Guide, 2021, 19(25): 124-125. DOI: 10.15912/j.cnki.gocm.2021.25.058.

[15] Stoichita A, Dumitrescu A, Ciobanu A, et al. Depression and anxiety symptoms among people with rifampicin-resistant tuberculosis receiving in-patient care in the National Pulmonology Reference Institute in Romania[J]. Monaldi Archives for Chest Disease, 2021, 91(1).

[16] Zhang Yi, Li Shuixia, Su Rina, et al. Analysis of risk factors for anxiety and depression in patients with chronic obstructive pulmonary disease[J]. Chinese and Foreign Medical Journal, 2023, 42(04): 33-37. DOI: 10.16662/j.cnki.1674-0742.2023.04.033.

[17] Shi Ga, Zheng Xiaojing, Lai Cuiping, et al. The mediating effect of psychological resilience and family support on the perioperative fear and anxiety symptoms in patients with lung cancer[J]. New Medical Knowledge, 2024, 34(03): 251-259.

[18] Chen B, Peng Y, Zhou L, et al. Social support received by multidrug-resistant tuberculosis patients and related factors: a cross-sectional study in Zhejiang Province, People’s Republic of China[J]. Patient preference and adherence, 2016: 1063-1070.

[19] Wang Chao. Analysis of the impact of humanistic care on negative emotions of patients with drug-resistant tuberculosis[J]. Journal of Qiqihar Medical College, 2019, 40(19): 2508-2509.

[20] Butnaru T, Mihălţan F D, Ancuţa C. The Impact on the Quality of Life of Patients with Drug-Resistant Tuberculosis–Brief Review[J]. Internal Medicine, 2024, 21(2): 65-78.

[21] Chen X, Du L, Wu R, et al. The effects of family, society and national policy support on treatment adherence among newly diagnosed tuberculosis patients: a cross-sectional study[J]. BMC infectious diseases, 2020, 20: 1-11.

[22] Zhang Xifeng. Progress in psychological nursing intervention for patients with multidrug-resistant tuberculosis[J]. Continuing Medical Education, 2019, 33(07): 66-68.